Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:4.2.2.7 (
heparinase
)
1,270
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Heparinase production by Flavobacterium heparinum in complex protein digest medium, with heparin employed as the inducer, has been studied and improved. The maximum productivity of
heparinase
has been increased 156-fold over that achieved by previously published methods to 375 U/liter per h in the complex medium. Rapid deactivation of
heparinase
activity, both specific and total, was observed at the onset of the stationary phase. Nutritional studies on growth and
heparinase
production showed an obligate requirement for L-histidine and no vitamin requirement. L-Methionine partially relieved the L-histidine requirement. A defined medium containing glucose, ammonium sulfate, basal salts, L-methionine, and L-histidine was developed for growth and
heparinase
production. The growth rate in this medium was 0.21 h-1, which is 40%, higher than that in complex medium. The maximum volumetric productivity of
heparinase
in the defined medium was increased to 1,475 U/liter per h, providing a 640-fold increase over that achieved by previously published methods. No rapid deactivation was observed. An examination of alternate inducers for
heparinase
showed that heparin degradation products, hyaluronic acid, heparin monosulfate,
N-acetyl-D-glucosamine
, and maltose, induce
heparinase
in complex medium. An Azure A assay was modified and fully developed to measure the heparin concentration during fermentation and the
heparinase
specific activity of crude extracts of F. heparinum obtained from sonication, thus negating the need for further purification to measure activity."
...
PMID:Heparinase production by Flavobacterium heparinum. 723 92